NEW YORK (GenomeWeb News) – PathoGenetix today said it has signed a collaborative agreement with the US Food and Drug Administration to evaluate the company's technology for use in foodborne illness outbreak investigation and response.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Kansas City Star examines issues surrounding newborn genome sequencing.
Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.
In Science this week: the Human Silencing Hub protein complex, and more.
Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.